Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical prednisolone and diclofenac for morphology of posterior capsule opacification
2004-004263-30Phase 4Completed
- Sponsor
- Oliver Findl
- Start
- Apr 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prednisolone sodium phosphate and diclofenac in posterior capsule opacification (PCO), sponsored by Oliver Findl. Primary endpoint: Morphological changes of posterior capsule opacification. Started Apr 2005; status: completed.
02
Drugs
prednisolone sodium phosphatediclofenac
03
Conditions
posterior capsule opacification (PCO)
Beyond the preview
Go deeper on 2004-004263-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004263-30.